Expression of Na +-K +-2Cl cotransporter 1 is epigenetically regulated during postnatal development of hypertension

American Journal of Hypertension

Volumn 24, Issue 12, 2011, Pages 1286-1293

  Cho, Hyun Min ^a   Lee, Hae Ahm ^a   Kim, Hye Young ^a   Han, Hyung Soo ^a   Kim, In Kyeom ^a  

^a Kyungpook National University School of Medicine   (South Korea)

Author keywords

blood pressure; DNA methylation; DNMT activity; epigenetics; histone modification; hypertension; NKCC1; SHR

Indexed keywords

BUMETANIDE; CXXC FINGER PROTEIN 1; DNA METHYLTRANSFERASE; HISTONE H3; MESSENGER RNA; NUCLEAR PROTEIN; PROTEIN; SODIUM POTASSIUM CHLORIDE COTRANSPORTER; SODIUM POTASSIUM CHLORIDE COTRANSPORTER 1; UNCLASSIFIED DRUG;

AGE DISTRIBUTION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DNA METHYLATION; ENZYME ACTIVITY; EPIGENETICS; GENETIC REGULATION; HISTONE CODE; HISTONE MODIFICATION; HYPERTENSION; MALE; MESENTERIC ARTERY; NONHUMAN; POSTNATAL DEVELOPMENT; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; RAT; TRANSCRIPTION REGULATION;

ANIMALS; AORTA; BUMETANIDE; DNA (CYTOSINE-5-)-METHYLTRANSFERASE; EPIGENOMICS; GENE EXPRESSION REGULATION; HISTONES; HYPERTENSION; MALE; MESENTERIC ARTERIES; PROMOTER REGIONS, GENETIC; RATS; RATS, INBRED SHR; RATS, INBRED WKY; SODIUM POTASSIUM CHLORIDE SYMPORTER INHIBITORS; SODIUM-POTASSIUM-CHLORIDE SYMPORTERS; TRANS-ACTIVATORS; UP-REGULATION;

EID: 81155150148     PISSN: 08957061     EISSN: 19417225     Source Type: Journal    
DOI: 10.1038/ajh.2011.136     Document Type: Article

References (33)

1. Gamba G. Molecular physiology and pathophysiology of electroneutral cationchloride cotransporters. Physiol Rev 2005; 85:423-493. (Pubitemid 40404634)
2. Anfinogenova YJ, Baskakov MB, Kovalev IV, Kilin AA, Dulin NO, Orlov SN. Cellvolume-dependent vascular smooth muscle contraction: role of Na+, K+, 2Cl-cotransport, intracellular Cl-and L-type Ca2+ channels. Pflugers Arch 2004; 449:42-55. (Pubitemid 39506355)
3. Meyer JW, Flagella M, Sutliff RL, Lorenz JN, Nieman ML, Weber CS, Paul RJ, Shull GE. Decreased blood pressure and vascular smooth muscle tone in mice lacking basolateral Na(+)-K(+)-2Cl(-) cotransporter. Am J Physiol Heart Circ Physiol 2002; 283:H1846-H1855. (Pubitemid 35217018)
4. Garg P, Martin CF, Elms SC, Gordon FJ, Wall SM, Garland CJ, Sutliff RL, O'Neill WC. Effect of the Na-K-2Cl cotransporter NKCC1 on systemic blood pressure and smooth muscle tone. Am J Physiol Heart Circ Physiol 2007; 292:H2100-H2105. (Pubitemid 47084588)
5. Koltsova SV, Kotelevtsev SV, Tremblay J, Hamet P, Orlov SN. Excitation-contraction coupling in resistance mesenteric arteries: evidence for NKCC1-mediated pathway. Biochem Biophys Res Commun 2009; 379:1080-1083.
6. Brown RA, Chipperfield AR, Davis JP, Harper AA. Increased (Na+K+Cl) cotransport in rat arterial smooth muscle in deoxycorticosterone (DOCA)/salt-induced hypertension. J Vasc Res 1999; 36:492-501. (Pubitemid 30020053)
7. Owen NE, Ridge KM. Mechanism of angiotensin II stimulation of Na-K-Cl cotransport of vascular smooth muscle cells. Am J Physiol 1989; 257:C629-C636.
8. Jiang G, Akar F, Cobbs SL, Lomashvilli K, Lakkis R, Gordon FJ, Sutliff RL, O'Neill WC. Blood pressure regulates the activity and function of the Na-K-2Cl cotransporter in vascular smooth muscle. Am J Physiol Heart Circ Physiol 2004; 286:H1552-H1557. (Pubitemid 38381167)
9. Jiang G, Cobbs S, Klein JD, O'Neill WC. Aldosterone regulates the Na-K-2Cl cotransporter in vascular smooth muscle. Hypertension 2003; 41:1131-1135. (Pubitemid 36548615)
10. Orlov SN, Adragna NC, Adarichev VA, Hamet P. Genetic and biochemical determinants of abnormal monovalent ion transport in primary hypertension. Am J Physiol 1999; 276:C511-C536. (Pubitemid 29157367)
11. Garay RP, Alda O. What can we learn from erythrocyte Na-K-Cl cotransporter NKCC1 in human hypertension? Pathophysiology 2007; 14:167-170. (Pubitemid 350176654)
12. Richardson C, Alessi DR. The regulation of salt transport and blood pressure by the WNK-SPAK/OSR1 signalling pathway. J Cell Sci 2008; 121:3293-3304.
13. Lee HA, Baek I, Seok YM, Yang E, Cho HM, Lee DY, Hong SH, Kim IK. Promoter hypomethylation upregulates Na+-K+-2Cl-cotransporter 1 in spontaneously hypertensive rats. Biochem Biophys Res Commun 2010; 396:252-257.
14. Yang E, Cho JY, Sohn UD, Kim IK. Calcium sensitization induced by sodium fluoride in permeabilized rat mesenteric arteries. Korean J Physiol Pharmacol 2010; 14:51-57.
15. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001; 25:402-408. (Pubitemid 34164012)
16. Herman JG, Graff JR, Myöhänen S, Nelkin BD, Baylin SB. Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci USA 1996; 93:9821-9826. (Pubitemid 26296693)
17. Lee HA, Hong SH, Kim JW, Jang IS. Possible involvement of DNA methylation in NKCC1 gene expression during postnatal development and in response to ischemia. J Neurochem 2010; 114:520-529.
18. Bogdarina I, Welham S, King PJ, Burns SP, Clark AJ. Epigenetic modification of the renin-angiotensin system in the fetal programming of hypertension. Circ Res 2007; 100:520-526. (Pubitemid 46673261)
19. Rivière G, Lienhard D, Andrieu T, Vieau D, Frey BM, Frey FJ. Epigenetic regulation of somatic angiotensin-converting enzyme by DNA methylation and histone acetylation. Epigenetics 2011; 6:478-489.
20. Thomson JP, Skene PJ, Selfridge J, Clouaire T, Guy J, Webb S, Kerr AR, Deaton A, Andrews R, James KD, Turner DJ, Illingworth R, Bird A. CpG islands influence chromatin structure via the CpG-binding protein Cfp1. Nature 2010; 464: 1082-1086.
21. Bird AP. CpG-rich islands and the function of DNA methylation. Nature 1986; 321:209-213. (Pubitemid 16016411)
22. Feinberg AP, Ohlsson R, Henikoff S. The epigenetic progenitor origin of human cancer. Nat Rev Genet 2006; 7:21-33. (Pubitemid 41828945)
23. Gopalakrishnan S, Van Emburgh BO, Robertson KD. DNA methylation in development and human disease. Mutat Res 2008; 647:30-38.
24. Krupanidhi S, Sedimbi SK, Sanjeevi CB. Epigenetics and epigenetic mechanisms in disease with emphasis on autoimmune diseases. J Assoc Physicians India 2008; 56:875-880.
25. Friso S, Pizzolo F, Choi SW, Guarini P, Castagna A, Ravagnani V, Carletto A, Pattini P, Corrocher R, Olivieri O. Epigenetic control of 11 beta-hydroxysteroid dehydrogenase 2 gene promoter is related to human hypertension. Atherosclerosis 2008; 199:323-327.
26. Matouk CC, Marsden PA. Epigenetic regulation of vascular endothelial gene expression. Circ Res 2008; 102:873-887. (Pubitemid 351591544)
27. Daniel JM, Reynolds AB. The catenin p120(ctn) interacts with Kaiso, a novel BTB/POZ domain zinc finger transcription factor. Mol Cell Biol 1999; 19:3614-3623. (Pubitemid 29193821)
28. Prokhortchouk A, Hendrich B, Jørgensen H, Ruzov A, Wilm M, Georgiev G, Bird A, Prokhortchouk E. The p120 catenin partner Kaiso is a DNA methylationdependent transcriptional repressor. Genes Dev 2001; 15:1613-1618. (Pubitemid 32702582)
29. Akar F, Jiang G, Paul RJ, O'Neill WC. Contractile regulation of the Na(+)-K(+)-2Cl(-) cotransporter in vascular smooth muscle. Am J Physiol, Cell Physiol 2001; 281:C579-C584.
30. Koltsova SV, Luneva OG, Lavoie JL, Tremblay J, Maksimov GV, Hamet P, Orlov SN. HCO3-dependent impact of Na+,K+,2Cl-cotransport in vascular smooth muscle excitation-contraction coupling. Cell Physiol Biochem 2009; 23:407-414.
31. Orlov SN. NKCC1 as a regulator of vascular tone and a novel target for antihypertensive therapeutics. Am J Physiol Heart Circ Physiol 2007; 292: H2035-H2036. (Pubitemid 47084585)
32. Orlov SN, Tremblay J, Hamet P. NKCC1 and hypertension: a novel therapeutic target involved in the regulation of vascular tone and renal function. Curr Opin Nephrol Hypertens 2010; 19:163-168.
33. Iwamoto LM, Gries DM, Nakamura KT. Loop diuretics and in vitro relaxation of human fetal and newborn mouse airways. Pediatr Res 2001; 50:273-276. (Pubitemid 32701204)